Guardant Health
GH
#1679
Rank
NZ$21.61 B
Marketcap
NZ$164.78
Share price
2.94%
Change (1 day)
117.31%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

We have found no dividend yield history for this company